Cargando…
A Review of Systemic Biologics and Local Immunosuppressive Medications in Uveitis
Uveitis is one of the most common causes of vision loss and blindness worldwide. Local and/or systemic immunosuppression is often required to treat ocular inflammation in noninfectious uveitis. An understanding of safety and efficacy of these medications is required to individualize treatment to eac...
Autores principales: | S. Mehta, Neesurg, Emami-Naeini, Parisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PUBLISHED BY KNOWLEDGE E
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185190/ https://www.ncbi.nlm.nih.gov/pubmed/35765634 http://dx.doi.org/10.18502/jovr.v17i2.10804 |
Ejemplares similares
-
Medication-induced Uveitis: An Update
por: Iqbal, Kashif M, et al.
Publicado: (2021) -
Review of Systemic Immunosuppression for Autoimmune Uveitis
por: Castiblanco, Claudia, et al.
Publicado: (2014) -
Trends in Remote Retinal Imaging Utilization and Payments in the United States
por: Lee, Sophie C., et al.
Publicado: (2022) -
Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration
por: Mehta, Neesurg, et al.
Publicado: (2023) -
Systemic immunosuppressive therapies for uveitis in developing countries
por: Agrawal, Hitesh, et al.
Publicado: (2020)